| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |